Dexcom gives sneak preview of CGM technologies’ long-term health benefits for diabetics

Dexcom will present the full data from several studies at the Advanced Technologies and Treatments for Diabetes conference, ...
PCMag Australia on MSN

I Tracked My Blood Sugar With a Dexcom Stelo for a Month. Here's What I Learned

The Stelo is available to anyone who wants to monitor their blood glucose, no prescription needed. But as an active adult ...
TMCnet

Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026

(NASDAQ:DXCM), the global leader in glucose biosensing, will present new findings that showcase the benefits of its glucose biosensing technology for people with all types of diabetes and share more ...

Diabetic glucose monitors recalled after 7 deaths, alarming patients

Patients alarmed after glucose monitors used by diabetics are recalled after links to 7 deaths - Abbott recalled certain sensors used in its FreeStyle Libre 3 and FreeStyle Libre 3 Plus systems, warni ...
Drug Delivery Business

Dexcom highlights breakthrough type 2 diabetes outcomes at ATTD

Dexcom (Nasdaq:DXCM) today announced its plans to share new data supporting its diabetes management technology at ATTD 2026.
Zacks Investment Research on MSN

Reasons to hold Tandem Diabetes stock in your portfolio for now

Tandem Diabetes Care, Inc.’s TNDM impressive product launches are expected to bolster growth in the upcoming quarters. A strong solvency looks encouraging. However, concerns loom over fierce ...

Diabetics who rely on glucose monitors are alarmed by recall linked to 7 deaths

A manufacturing problem in Abbott glucose sensors for diabetes patients has been tied to at least seven deaths and hundreds ...

We tried continuous glucose monitors from Lingo and Stelo for 2 weeks. Here’s which one is better

Our editors tested two popular glucose monitors to determine which is the best for improving ​​diet, sleep and exercise habits.

First Ever Real-World Evidence of Eversense 365 Presented at ATTD Demonstrates Sustained Performance and Positive Impact Throughout One-Year of Wear

New data shows positive real-world impact of the world’s first and only one-year CGM, with a full year of strong patient adherence, glucometrics ...
Physician's Weekly

Q&A: Evaluating the Compatibility of Wearable Neuromodulation Therapy & Continuous Glucose Monitoring Systems

New data show that wearable neuromodulation can be used with CGMs without disrupting glucose accuracy or connectivity.

Are Wearable Trackers Accurate? A Doctor Explains The Data On 9 Brands

From the Oura Ring to the Apple Watch to the Google Pixel — here's what the science really says about the accuracy of their health data ...